Wen Z, Liu T, Xu X, Acharya N, Shen Z, Lu Y
Nat Commun. 2025; 16(1):2362.
PMID: 40064918
PMC: 11893787.
DOI: 10.1038/s41467-025-57603-1.
Guan X, Wang Y, Fang T, Wang J, Li R, Hao M
Haematologica. 2024; 110(2):425-438.
PMID: 39323416
PMC: 11788625.
DOI: 10.3324/haematol.2024.285304.
Tsareva A, Shelyakin P, Shagina I, Myshkin M, Merzlyak E, Kriukova V
Front Immunol. 2024; 15:1380971.
PMID: 38799462
PMC: 11116662.
DOI: 10.3389/fimmu.2024.1380971.
Reyes-Farias M, Fernandez-Garcia P, Corrales P, Gonzalez L, Soria-Gondek A, Martinez E
Front Endocrinol (Lausanne). 2024; 15:1346317.
PMID: 38544694
PMC: 10965774.
DOI: 10.3389/fendo.2024.1346317.
Izraelson M, Metsger M, Davydov A, Shagina I, Dronina M, Obraztsova A
Nat Aging. 2023; 1(2):179-189.
PMID: 37118630
DOI: 10.1038/s43587-021-00029-3.
IFNγ-induction of T1-like regulatory T cells controls antiviral responses.
Gocher-Demske A, Cui J, Szymczak-Workman A, Vignali K, Latini J, Pieklo G
Nat Immunol. 2023; 24(5):841-854.
PMID: 36928412
PMC: 10224582.
DOI: 10.1038/s41590-023-01453-w.
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
Hayry A, Faustini F, Zickert A, Larsson A, Niewold T, Svenungsson E
Lupus Sci Med. 2022; 9(1).
PMID: 36104119
PMC: 9476119.
DOI: 10.1136/lupus-2022-000744.
Commensal oral microbiota induces osteoimmunomodulatory effects separate from systemic microbiome in mice.
Hathaway-Schrader J, Aartun J, Poulides N, Kuhn M, McCormick B, Chew M
JCI Insight. 2022; 7(4).
PMID: 35077397
PMC: 8876522.
DOI: 10.1172/jci.insight.140738.
microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer.
Fang W, Shi C, Wang Y, Song J, Zhang L
Bioengineered. 2021; 13(1):1025-1038.
PMID: 34968167
PMC: 8805824.
DOI: 10.1080/21655979.2021.2017566.
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients.
Zarzuelo-Romero M, Perez-Ramirez C, Cura Y, Carrasco-Campos M, Marangoni-Iglecias L, Ramirez-Tortosa M
J Pers Med. 2021; 11(10).
PMID: 34683173
PMC: 8540092.
DOI: 10.3390/jpm11101032.
Increased Levels of IL-16 in the Central Nervous System during Neuroinflammation Are Associated with Infiltrating Immune Cells and Resident Glial Cells.
Hridi S, Barbour M, Wilson C, Franssen A, Harte T, Bushell T
Biology (Basel). 2021; 10(6).
PMID: 34071825
PMC: 8229350.
DOI: 10.3390/biology10060472.
Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation.
Liu S, Lei Z, Li J, Wang L, Jia R, Liu Z
PLoS Pathog. 2020; 16(7):e1008701.
PMID: 32735617
PMC: 7423151.
DOI: 10.1371/journal.ppat.1008701.
Inferring Regulatory Networks From Mixed Observational Data Using Directed Acyclic Graphs.
Zhong W, Dong L, Poston T, Darville T, Spracklen C, Wu D
Front Genet. 2020; 11:8.
PMID: 32127796
PMC: 7038820.
DOI: 10.3389/fgene.2020.00008.
High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia.
Wang X, Li L, Wang Y, Li X, Feng Q, Hou Y
Front Immunol. 2019; 10:451.
PMID: 30936868
PMC: 6431608.
DOI: 10.3389/fimmu.2019.00451.
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment.
Drakes M, Stiff P
Cancers (Basel). 2018; 10(9).
PMID: 30200478
PMC: 6162424.
DOI: 10.3390/cancers10090302.
The Inhibitory Effect of Ectromelia Virus Infection on Innate and Adaptive Immune Properties of GM-CSF-Derived Bone Marrow Cells Is Mouse Strain-Independent.
Szulc-Dabrowska L, Struzik J, Cymerys J, Winnicka A, Nowak Z, Toka F
Front Microbiol. 2018; 8:2539.
PMID: 29312229
PMC: 5742134.
DOI: 10.3389/fmicb.2017.02539.
Novel therapeutic interventions for pseudoachondroplasia.
Posey K, Hecht J
Bone. 2017; 102:60-68.
PMID: 28336490
PMC: 6168010.
DOI: 10.1016/j.bone.2017.03.045.
Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.
Dondeti M, El-Maadawy E, Talaat R
World J Gastroenterol. 2016; 22(30):6800-16.
PMID: 27570418
PMC: 4974580.
DOI: 10.3748/wjg.v22.i30.6800.
Secondary necrotic neutrophils release interleukin-16C and macrophage migration inhibitory factor from stores in the cytosol.
Roth S, Agthe M, Eickhoff S, Moller S, Karsten C, Borregaard N
Cell Death Discov. 2016; 1:15056.
PMID: 27551482
PMC: 4979515.
DOI: 10.1038/cddiscovery.2015.56.
Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.
Halvorsen E, Hamilton M, Young A, Wadsworth B, LePard N, Lee H
Oncoimmunology. 2016; 5(6):e1150398.
PMID: 27471618
PMC: 4938322.
DOI: 10.1080/2162402X.2016.1150398.